MedPath
HSA Approval

A-TADALAFIL FILM-COATED TABLETS 20 MG

SIN16934P

A-TADALAFIL FILM-COATED TABLETS 20 MG

A-TADALAFIL FILM-COATED TABLETS 20 MG

January 26, 2024

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

G04BE08

tadalafil

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

MICRO LABS LIMITED

Active Ingredients

Tadalafil

20mg

Tadalafil

Documents

Package Inserts

A-Tadalafil Film-Coated Tablets PI.pdf

Approved: January 26, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

A-TADALAFIL FILM-COATED TABLETS 20 MG - HSA Approval | MedPath